The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
A Dual Role of Heme Oxygenase-1 in Cancer Cells
Open accessAbstract
Heme oxygenase (HO)-1 is known to metabolize heme into biliverdin/bilirubin, carbon monoxide, and ferrous iron, and it has been suggested to demonstrate cytoprotective effects against various stress-related conditions. HO-1 is commonly regarded as a survival molecule, exerting an important role in cancer progression and its inhibition is considered beneficial in a number of cancers. However, increasing studies have shown a dark side of HO-1, in which HO-1 acts as a critical mediator in ferroptosis induction and plays a causative factor for the progression of several diseases. Ferroptosis is a newly identified iron- and lipid peroxidation-dependent cell death. The critical role of HO-1 in heme metabolism makes it an important candidate to mediate protective or detrimental effects via ferroptosis induction. This review summarizes the current understanding on the regulatory mechanisms of HO-1 in ferroptosis. The amount of cellular iron and reactive oxygen species (ROS) is the determinative momentum for the role of HO-1, in which excessive cellular iron and ROS tend to enforce HO-1 from a protective role to a perpetrator. Despite the dark side that is related to cell death, there is a prospective application of HO-1 to mediate ferroptosis for cancer therapy as a chemotherapeutic strategy against tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A., & Dulak, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2223-0 · Cited by 2,632
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876 · cited 2×
“Upregulation of transferrin receptor 1 resulted in a higher sensitivity to ferroptosis induction [58,59].”
BackgroundCao, J. Y., & Dixon, S. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2194-1 · Cited by 1,515
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“Under resting conditions, Nrf2 activity is inhibited by physical interaction with Kelch-like ECH-associated protein 1 (Keap1), leading to the recruitment of Cullin-3-dependent E3 ubiquitin ligase for proteasomal degradation, thereby maintaining Nrf2 at a low level [37].”
BackgroundHeme Enzyme Structure and Function
Poulos, T. L. (2014) · Chemical Reviews · doi:10.1021/cr400415k · Cited by 1,443
Oxidative stress inhibits distant metastasis by human melanoma cells
Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., Leitch, A. M., Johnson, T. M., DeBerardinis, R. J., & Morrison, S. J. (2015) · Nature · doi:10.1038/nature15726 · Cited by 1,269
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241
Pharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070
Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T., & Gerritsen, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21096 · Cited by 1,053
Metals, oxidative stress and neurodegenerative disorders
Jomova, K., Vondrakova, D., Lawson, M., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,052
Cancer cell killing via ROS: To increase or decrease, that is the question
Wang, J., & Yi, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7067 · Cited by 790
Dowdle, W. E., Nyfeler, B., Nagel, J., Elling, R. A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3053 · Cited by 759
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2012-11-451229 · Cited by 754
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
Roh, J.-L., Kim, E. H., Jang, H., & Shin, D. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.010 · Cited by 662
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
Hassannia, B., Wiernicki, B., Ingold, I., Qu, F., Van Herck, S., Tyurina, Y. Y., Bayır, H., Abhari, B. A., Angeli, J. P. F., Choi, S. M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99032 · Cited by 627
Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
Kwon, M.-Y., Park, E., Lee, S.-J., & Chung, S. W. (2015) · Oncotarget · doi:10.18632/oncotarget.5162 · Cited by 612
Salinomycin kills cancer stem cells by sequestering iron in lysosomes
Mai, T. T., Hamaï, A., Hienzsch, A., Cañeque, T., Müller, S., Wicinski, J., Cabaud, O., Leroy, C., David, A., Acevedo, V., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2778 · Cited by 612
Timmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · cited 1×
“Certain cancer cells, such as pancreatic cancer cell lines (MIA PaCa-2, PANC-1, and BxPC-3) and a subset of triple-negative cancer cells also greatly depend on system Xc− to mediate cysteine uptake for growth, as well as survival under oxidative stress conditions [24,25], suggesting that system Xc− might serve as a go…”
BackgroundIntracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Chang, L.-C., Chiang, S.-K., Chen, S.-E., Yu, Y.-L., Chou, R.-H., & Chang, W.-C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.12.025 · Cited by 521
Self-citationThe Role of Ferroptosis in Cancer Development and Treatment Response
Lu, B., Chen, X. B., Ying, M. D., He, Q. J., Cao, J., & Yang, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00992 · Cited by 444
Reversal of HO‐1 related cytoprotection with increased expression is due to reactive iron
Suttner, D. M., & Dennery, P. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1800 · Cited by 424
Lin, Q., Weis, S., Yang, G., Weng, Y.-H., Helston, R., Rish, K., Smith, A., Bordner, J., Polte, T., Gaunitz, F., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607954200 · Cited by 416
Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1
Reichard, J. F., Motz, G. T., & Puga, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm638 · Cited by 394
Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells
Adedoyin, O., Boddu, R., Traylor, A., Lever, J. M., Bolisetty, S., George, J. F., & Agarwal, A. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00044.2017 · Cited by 368
p62/SQSTM1: A Missing Link between Protein Aggregates and the Autophagy Machinery
Bjørkøy, G., Lamark, T., & Johansen, T. (2006) · Autophagy · doi:10.4161/auto.2.2.2405 · Cited by 322
Clark, J., Foresti, R., Green, C. J., & Motterlini, R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480615 · Cited by 313
Berberat, P. O., Dambrauskas, Z., Gulbinas, A., Giese, T., Giese, N., Künzli, B., Autschbach, F., Meuer, S., Büchler, M. W., & Friess, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2159 · Cited by 263
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
Iron in multiple sclerosis: roles in neurodegeneration and repair
Stephenson, E., Nathoo, N., Mahjoub, Y., Dunn, J. F., & Yong, V. W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.118 · Cited by 248
Hamacher-Brady, A., Stein, H. A., Turschner, S., Toegel, I., Mora, R., Jennewein, N., Efferth, T., Eils, R., & Brady, N. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210047 · Cited by 230
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation
Nitti, M., Piras, S., Marinari, U., Moretta, L., Pronzato, M., & Furfaro, A. (2017) · Antioxidants · doi:10.3390/antiox6020029 · Cited by 223
Lo, M., Ling, V, Wang, Y. Z., & Gout, P. W. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604485 · Cited by 221
The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress‐Mediated Diseases
(2007) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(06)43001-8 · Cited by 209
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
Na, H.-K., & Surh, Y.-J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.819 · Cited by 202
Loboda, A., Jozkowicz, A., & Dulak, J. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.004 · Cited by 186
Appleton, S. D., Chretien, M. L., McLaughlin, B. E., Vreman, H. J., Stevenson, D. K., Brien, J. F., Nakatsu, K., Maurice, D. H., & Marks, G. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15048-9 · Cited by 184
HO‐1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism
Converso, D. P., Taillé, C., Carreras, M. C., Jaitovich, A., Poderoso, J. J., Boczkowski, J., Converso, D. P., Taillé, C., Carreras, M. C., Jaitovich, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4204fje · Cited by 177
Antimalarial Action of Artesunate Involves DNA Damage Mediated by Reactive Oxygen Species
Gopalakrishnan, A. M., & Kumar, N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03663-14 · Cited by 174
Heme oxygenase-1 regulates mitochondrial quality control in the heart
Hull, T. D., Boddu, R., Guo, L., Tisher, C. C., Traylor, A. M., Patel, B., Joseph, R., Prabhu, S. D., Suliman, H. B., Piantadosi, C. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85817 · Cited by 168
Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo
Chi, L., Ke, Y., Luo, C., Gozal, D., & Liu, R. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.064 · Cited by 167
Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action
Lee, I.-C., & Choi, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030290 · Cited by 165
Cardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Nitti, M., Piras, S., Brondolo, L., Marinari, U. M., Pronzato, M. A., & Furfaro, A. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082260 · Cited by 161
Fang, J. Q., Sawa, T., Akaike, T., Greish, K. F., & Maeda, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11644 · Cited by 157
Sui, M., Jiang, X., Chen, J., Yang, H., & Zhu, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.060 · Cited by 155
Hirai, K., Sasahira, T., Ohmori, H., Fujii, K., & Kuniyasu, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22287 · Cited by 153
Bansal, S., Biswas, G., & Avadhani, N. G. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.004 · Cited by 153
Kang, K. A., Piao, M. J., Kim, K. C., Kang, H. K., Chang, W. Y., Park, I. C., Keum, Y. S., Surh, Y. J., & Hyun, J. W. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.149 · Cited by 149
The Role of Reactive Oxygen Species and Ferroptosis in Heme-Mediated Activation of Human Platelets
NaveenKumar, S. K., SharathBabu, B. N., Hemshekhar, M., Kemparaju, K., Girish, K. S., & Mugesh, G. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00458 · Cited by 137
Vyas, A. R., & Singh, S. V. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9531-1 · Cited by 136
Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury
Bolisetty, S., Zarjou, A., & Agarwal, A. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.037 · Cited by 134
Iron-regulatory proteins: molecular biology and pathophysiological implications
Cairo, G., & Recalcati, S. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000531 · Cited by 124
Zhang, Y., Mikhael, M., Xu, D., Li, Y., Soe-Lin, S., Ning, B., Li, W., Nie, G., Zhao, Y., & Ponka, P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3129 · Cited by 120
Hori, R., Kashiba, M., Toma, T., Yachie, A., Goda, N., Makino, N., Soejima, A., Nagasawa, T., Nakabayashi, K., & Suematsu, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107749200 · Cited by 114
Kim, H.-R., Kim, S.-J., Kim, E., Park, J., Yang, S., Jeong, E., Park, C., Youn, M., So, H., & Park, R. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.09.021 · Cited by 114
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo
Nuhn, P., Künzli, B. M., Hennig, R., Mitkus, T., Ramanauskas, T., Nobiling, R., Meuer, S. C., Frieß, H., & Berberat, P. O. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-37 · Cited by 112
Sass, G., Leukel, P., Schmitz, V., Raskopf, E., Ocker, M., Neureiter, D., Meissnitzer, M. W., Tasika, E., Tannapfel, A., & Tiegs, G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23695 · Cited by 100
Bilirubin Inhibits Tumor Cell Growth via Activation of ERK
Öllinger, R., Kogler, P., Troppmair, J., Hermann, M., Wurm, M., Drasche, A., Königsrainer, I., Amberger, A., Weiss, H. G., Öfner, D., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.24.5022 · Cited by 99
Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway
Busserolles, J., Megías, J., Terencio, M. C., & Alcaraz, M. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.013 · Cited by 99
Mayerhofer, M., Gleixner, K. V., Mayerhofer, J., Hoermann, G., Jaeger, E., Aichberger, K. J., Ott, R. G., Greish, K. F., Nakamura, H., Derdak, S. V., et al. (2007) · Blood · doi:10.1182/blood-2006-11-055723 · Cited by 96
Heme oxygenase inhibition in cancers: possible tools and targets
Podkalicka, P., Mucha, O., Józkowicz, A., Dulak, J., & Łoboda, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73879 · Cited by 94
Frank, J., Lornejad‐Schäfer, M. R., Schöffl, H., Flaccus, A., Lambert, C., & Biesalski, H. K. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1539 · Cited by 90
Drug-induced hepatotoxicity in cancer patients - implication for treatment
Vincenzi, B., Armento, G., Ceruso, M. S., Catania, G., Leakos, M., Santini, D., Minotti, G., & Tonini, G. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1194824 · Cited by 89
Endoplasmic reticulum anchored heme-oxygenase 1 faces the cytosol
Gottlieb, Y., Truman-Rosentsvit, M., Cohen, L. A., Leichtmann‐Bardoogo, Y., & Meyron‐Holtz, E. G. (2012) · Haematologica · doi:10.3324/haematol.2012.063651 · Cited by 88
Role of heme oxygenase in preserving vascular bioactive NO
Pae, H., Son, Y. H., Kim, N., Jeong, H. J., Chang, K. C., & Chung, H. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.08.002 · Cited by 84
Banerjee, P., Basu, A., Wegiel, B., Otterbein, L. E., Mizumura, K., Gasser, M., Waaga-Gasser, A. M., Choi, A. M. K., & Pal, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393140 · Cited by 84
Kinobe, R. T., Vlahakis, J. Z., Vreman, H. J., Stevenson, D. K., Brien, J. F., Szarek, W. A., & Nakatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706555 · Cited by 74
Imidazole−Dioxolane Compounds as Isozyme-Selective Heme Oxygenase Inhibitors
Vlahakis, J. Z., Kinobe, R. T., Bowers, R. J., Brien, J. F., Nakatsu, K., & Szarek, W. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0511435 · Cited by 72
Heyninck, K., Sabbe, L., Chirumamilla, C. S., Szic, K. S. V., der Veken, P. V., Lemmens, K. J. A., Lahtela-Kakkonen, M. K., Naulaerts, S., de Beeck, K. O., Laukens, K., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.026 · Cited by 69
Lamb, N. J., Quinlan, G. J., Mumby, S. E., Evans, T. W., & Gutteridge, J. M. C. (1999) · Biochemical Journal · doi:10.1042/bj3440153 · Cited by 67
Tibullo, D., Barbagallo, I. A., Giallongo, C., Vanella, L., Conticello, C., Romano, A., Saccone, S., Godos, J., Raimondo, F. D., & Volti, G. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7563 · Cited by 67
Acute iron overload and oxidative stress in brain
Piloni, N. E., Fermandez, V., Videla, L. A., & Puntarulo, S. (2013) · Toxicology · doi:10.1016/j.tox.2013.09.015 · Cited by 66
Salerno, L., Pittalà, V., Romeo, G., Modica, M. N., Marrazzo, A., Siracusa, M. A., Sorrenti, V., Giacomo, C. D., Vanella, L., Parayath, N. N., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.003 · Cited by 63
Lin, P.-H., Chiang, M., & Chau, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.008 · Cited by 63
Haem oxygenase-1 overexpression alters intracellular iron distribution
Lanceta, L., Li, C., Choi, A. M. K., & Eaton, J. W. (2012) · Biochemical Journal · doi:10.1042/bj20120936 · Cited by 58
Zhu, X., LI, W., MA, J.-Y., Shao, N., Zhang, Y., Liu, R.-M., WU, W.-B., Lin, Y., & Wang, S.-M. (2015) · Oncology Letters · doi:10.3892/ol.2015.3735 · Cited by 57
Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia
Salerno, L., Romeo, G., Modica, M. N., Amata, E., Sorrenti, V., Barbagallo, I. A., & Pittalà, V. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.031 · Cited by 57
Induction of Ferritin Synthesis in Human Lung Epithelial Cells Treated with Crocidolite Asbestos
Fang, R., & Aust, A. E. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9892 · Cited by 52 · cited 1×
“In cultured alveolar epithelial cells, HO-1 overexpression increased the expression of ferritin and transferrin receptor, resulting in the alteration of the intracellular iron distribution and providing a protective effect against iron cytotoxicity from heme degradation [70].”
BackgroundGreish, K. F., Salerno, L., Alzahrani, R., Amata, E., Modica, M. N., Romeo, G., Marrazzo, A., Prezzavento, O., Sorrenti, V., Rescifina, A., et al. (2018) · Molecules · doi:10.3390/molecules23051209 · Cited by 51
Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin
Liu, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8572 · Cited by 42
Sorrenti, V., Pittalà, V., Romeo, G., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.048 · Cited by 41
Heme Oxygenase-1 Induction and Dependent Increase in Ferritin
Gonzales, S., Erario, M., & Tomaro, M. L. (2002) · Developmental Neuroscience · doi:10.1159/000065686 · Cited by 38
Wang, Y., Zhang, Z., Wang, X., Qi, D., Qu, A., & Wang, G. (2017) · Mediators of Inflammation · doi:10.1155/2017/3526903 · Cited by 36
Bekeschus, S., Freund, E., Wende, K., Gandhirajan, R. K., & Schmidt, A. (2018) · Antioxidants · doi:10.3390/antiox7110151 · Cited by 35
Zheng, J., Nagda, D. A., Lajud, S. A., Kumar, S., Mouchli, A., Bezpalko, O., O'Malley, B. W., & Li, D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.98 · Cited by 33
Han, L., Jiang, J., Ma, Q., Wu, Z., & Wang, Z. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4363 · Cited by 33
Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy
Shi, L., & Fang, J. Q. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-13 · Cited by 31
Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors
Rahman, M. N., Vlahakis, J. Z., Roman, G., Vukomanovic, D., Szarek, W. A., Nakatsu, K., & Jia, Z. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.10.011 · Cited by 30
Preservation solution supplemented with biliverdin prevents lung cold ischaemia/reperfusion injury
Sugimoto, R., Tanaka, Y., Noda, K., Kawamura, T., Toyoda, Y., Billiar, T. R., McCurry, K. R., & Nakao, A. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs298 · Cited by 29
Kovacsics, C. E., Gill, A. J., Ambegaokar, S. S., Gelman, B. B., & Kolson, D. L. (2017) · Glia · doi:10.1002/glia.23160 · Cited by 26
Mucha, O., Podkalicka, P., Czarnek, M., Biela, A., Mieczkowski, M., Kachamakova‐Trojanowska, N., Stępniewski, J., Józkowicz, A., Dulak, J., & Łoboda, A. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_2542 · Cited by 26
ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity
Shang, F., Hui, L., An, X., et al. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.03.005 · Cited by 20
Cheng, B., Tang, S., Zhe, N., Ma, D., Yu, K., Wei, D., Zhou, Z., Lu, T., Wang, J., & Fang, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.039 · Cited by 17
Cited by
Lipid peroxidation and ferroptosis: The role of GSH and GPx4
Ursini, F., & Maiorino, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.027 · Cited by 1,954
Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis
Rochette, L., Dogon, G., Rigal, E., Zeller, M., Cottin, Y., & Vergely, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010449 · Cited by 919
Molecular mechanisms of ferroptosis and its role in cancer therapy
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14511 · Cited by 639
Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
Battaglia, A. M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., & Biamonte, F. (2020) · Cells · doi:10.3390/cells9061505 · Cited by 561
The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy
Zhao, Y., Li, Y., Zhang, R., Wang, F., Wang, T., & Jiao, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s254995 · Cited by 458
Metadata
- Authors
- Chiang, S.-K., Chen, S.-E., & Chang, L.-C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-12-21
- Volume
- 20
- Issue
- 1
- Pages
- 39
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2905675459
- Cited by
- 465
- References
- 109
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.